Character Biosciences Expands Leadership Team, Announces Series B Extension
Character Biosciences, a precision medication firm remodeling drug improvement for polygenic illnesses, right now introduced the growth of its management group with 4 senior appointments, together with Robert Kim, M.D., MBA as Chief Medical Officer, Daniel Elgort, Ph.D. as Chief Data & Analytics Officer, Josh Buddle as Head of Clinical Network and Longitudinal Research, and…
